Melbourne Medical School Collected Works - Research Publications

Permanent URI for this collection

Search Results

Now showing 1 - 9 of 9
  • Item
    Thumbnail Image
    Social Prescribing the Smart City
    Pedell, S ; Borda, A (BCS Learning & Development, 2021-07)
  • Item
    Thumbnail Image
    Injecting drug use is an independent risk factor for reincarceration after release from prison: A prospective cohort study
    Winter, RJ ; Stoove, M ; Agius, PA ; Hellard, ME ; Kinner, SA (WILEY, 2019-03-01)
    INTRODUCTION AND AIMS: Once involved in the criminal justice system, people who inject drugs (PWID) have a high probability of multiple system encounters. Imprisonment typically fails to rehabilitate PWID, who upon return to the community are at considerable risk of returning to injecting drug use (IDU) and poor health and social outcomes. We examined the effect of IDU resumption, and a suite of other sociodemographic, criminogenic, health and behavioural indicators, on the timing of reincarceration among adults with a history of IDU following release from prison. DESIGN AND METHODS: Structured interviews were conducted with 561 PWID in Queensland, Australia prior to release from prison and approximately 1, 3 and 6 months post-release. Data were linked prospectively with correctional records and the National Death Index. Data collected at multiple time-points were treated as time-varying covariates. Kaplan-Meier survival estimates and Cox proportional hazards models were used to estimate the rate and hazards of reincarceration. RESULTS: Sixty-eight percent of participants (n = 350) were reincarcerated over a combined observation time of 1043.5 years, representing a rate of 33.5 per 100 person-years (95% confidence interval [CI] 30.2-37.2). Time-invariant predictors of reincarceration in PWID were: male gender (adjusted hazard ratio [AHR] = 1.62, 95% CI 1.19-2.21), older age at release (AHR = 0.97, 95% CI 0.95-1.00), previous adult (AHR = 2.00, 95% CI 1.41-2.84) or juvenile (AHR = 1.78, 95% CI 1.27-2.49) imprisonment, shorter imprisonment (≤90 days vs. >365 days, AHR = 2.09, 95% CI 1.30-3.34), release on parole (AHR = 2.29, 95% CI 1.82-2.88) and drug-related sentence (AHR = 1.84, 95% CI 1.34-2.53). Time-varying predictors included resumption of IDU (AHR = 2.04, 95% CI 1.60-2.61), unemployment (AHR = 1.53, 95% CI 1.07-2.19) and low perceived social support (AHR = 1.41, 95% CI 1.05-1.90). Very-high psychological distress at the most recent interview was protective against reincarceration (AHR = 0.65, 95% CI 0.44-0.95). DISCUSSION AND CONCLUSIONS: Efforts to prevent resumption of IDU and address disadvantage, social inclusion and health service access in ex-prisoners through the scale-up and integration of prison-based and post-release interventions are likely to reap both public health and criminal justice benefits.
  • Item
    Thumbnail Image
    Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012"
    Ascierto, PA ; Grimaldi, AM ; Acquavella, N ; Borgognoni, L ; Calabro, L ; Cascinelli, N ; Cesano, A ; Del Vecchio, M ; Eggermont, AM ; Faries, M ; Ferrone, S ; Fox, BA ; Gajewski, TF ; Galon, J ; Gnjatic, S ; Gogas, H ; Kashani-Sabet, M ; Kaufman, HL ; Larkin, J ; Lo, RS ; Mantovani, A ; Margolin, K ; Melief, C ; McArthur, G ; Palmieri, G ; Puzanov, I ; Ribas, A ; Seliger, B ; Sosman, J ; Suenaert, P ; Tarhini, AA ; Trinchieri, G ; Vidal-Vanaclocha, F ; Wang, E ; Ciliberto, G ; Mozzillo, N ; Marincola, FM ; Thurin, M (BMC, 2013-06-03)
    Recent insights into the genetic and somatic aberrations have initiated a new era of rapidly evolving targeted and immune-based treatments for melanoma. After decades of unsuccessful attempts to finding a more effective cure in the treatment of melanoma now we have several drugs active in melanoma. The possibility to use these drugs in combination to improve responses to overcome the resistance, to potentiate the action of immune system with the new immunomodulating antibodies, and identification of biomarkers that can predict the response to a particular therapy represent new concepts and approaches in the clinical management of melanoma. The third "Melanoma Research: "A bridge from Naples to the World" meeting, shortened as "Bridge Melanoma Meeting" took place in Naples, December 2 to 4th, 2012. The four topics of discussion at this meeting were: advances in molecular profiling and novel biomarkers, combination therapies, novel concepts toward integrating biomarkers and therapies into contemporary clinical management of patients with melanoma across the entire spectrum of disease stage, and the knowledge gained from the biology of tumor microenvironment across different tumors as a bridge to impact on prognosis and response to therapy in melanoma. This international congress gathered more than 30 international faculty members who in an interactive atmosphere which stimulated discussion and exchange of their experience regarding the most recent advances in research and clinical management of melanoma patients.
  • Item
    No Preview Available
    Numerical investigation of the behaviour of wall shear stress in three-dimensional pulsatile stenotic flows
    Li, S ; Chin, C ; Barlis, P ; MARUSIC, I ; Ooi, A (Australasian Fluid Mechanics Society (AFMS), 2014)
  • Item
    Thumbnail Image
    Securing interpretability: The case of ega language documentation
    Gibbon, D ; Bow, C ; Bird, S ; Hughes, B (Evaluations and Language resources Distribution Agency, 2004-01-01)
  • Item
    Thumbnail Image
    Quantifying the reuse of learning objects
    Elliott, K ; Sweeney, K (Australasian Society for Computers in Learning in Tertiary Education, 2007-12-01)
  • Item
  • Item
    Thumbnail Image
    Podcasting: Is it a technology for informal peer learning?
    Petrovic, T ; Kennedy, G ; Chang, R ; Waycott, J (ASCILITE, 2008-12-01)
  • Item
    Thumbnail Image
    Knowledge, wisdom and a holistic approach: a case study of change-management in academic development
    CHANG, R ; Wahr, F ; De Pew, D ; GRAY, K ; Jansz-Senn, A ; Radloff, A (HERDSA, 2004)